SuperGen ceo joins BIO board
James Manuso joins the US-based biotechnology organisation
BIO’s board includes members of the governing boards for each of the organisation’s four sections: health, emerging companies, industrial and environmental and food and agriculture. Manuso has joined BIO’s health section governing board.
In addition, Manuso will serve on the BIO board Standing Committee on International Affairs.
SuperGen has been a member of BIO since 2003.
Manuso has been SuperGen chairman, president and chief executive since January 2004. He is co-founder and immediate past president and chief executive of Galenica Pharmaceuticals.
The Biotechnology Industry Organization (BIO) represents more than 1,100 biotechnology companies, academic institutions, biotechnology centres and related organisations across the US and in more than 30 other nations.
BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
You may also like
Manufacturing
WLS introduces PR-12 and PR-24 plunger rod insertion and labelling systems
By improving reliability and streamlining production, the PR-12 and PR-24 help pharmaceutical manufacturers and contract packers protect product quality and reduce waste while maximising operational efficiencies
Pharmaceutical
Azelis strengthens its footprint in Italy with the acquisition of Azienda Chimica e Farmaceutica (‘ACEF’)
Azelis is pleased to announce that it has acquired 100% of the shares of Azienda Chimica e Farmaceutica (‘ACEF’), a distributor of speciality raw materials and ingredients for the cosmetic, nutraceutical, galenic and pharma industries in Italy
Manufacturing
Atlas Copco expands oil-free compressor range to support critical pharmaceutical air quality standards
Atlas Copco has expanded its oil-free compressor portfolio with cutting-edge models engineered to exceed pharmaceutical air quality standards and improve energy efficiency across critical manufacturing environments